Esper Boel

4.6k citations

54 papers · 3.8k indexed · h-index 33

Impact in

Biotechnology top 0.5%
- Enzyme Production and Characterization
Endocrinology, Diabetes and Metabolism top 1%
- Diabetes Management and Research

Papers in

Clinical Biochemistry 5
- Advanced Glycation End Products research 5
Biotechnology 6
- Enzyme Production and Characterization 6

Co-authors: Niels P. Fiil Allan E. Karlsen Kjeld Norris B Michelsen Thomas Dyrberg Lars Thim Mogens Trier Hansen William Hagopian
Journals: Diabetes (6 papers)Diabetologia (6 papers)Biochemistry (5 papers)FEBS Letters (5 papers)Proceedings of the National Academy of Sciences (4 papers)
Partner nations: Denmark United States Sweden

In The Last Decade

Esper Boel

54 papers receiving 3.7k citations

Peers

Countries citing papers authored by Esper Boel

Since Specialization

Citations

This map shows the geographic impact of Esper Boel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esper Boel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esper Boel more than expected).

Fields of papers citing papers by Esper Boel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esper Boel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esper Boel. The network helps show where Esper Boel may publish in the future.

Co-authors

The 25 scholars most cited alongside Esper Boel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esper Boel Line = papers co-authored together Esper Boel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients Diabetic Medicine ·Maria Lajer, Lise Tarnow, Jan Fleckner, Birgitte V. Hansen, Inago Cédric Arnaud, PEÑA Gerardo X., Esper Boel	2004	19
2	Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats Metabolism ·Peter Oturai, Mogens Christensen, Bidda Rolin, Norito Takaki, Steen B. Mortensen, Esper Boel	2000	31
3	Health Care Discovery, Novo Nordisk A/S, DK-2880 Bagsværd, Denmark Current Pharmaceutical Biotechnology ·Esper Boel, Tatjana Albrektsen, Jan Fleckner, Cong Juan	2000	4
4	A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes Diabetologia ·Tina Soulis, Stephen A. Sastra, Vicki Thallas, Steen B. Mortensen, Michael Wilken, Jes Thorn Clausen, Ole J. Bjerrum, H. Petersen, Jesper Lau, George Jerums, Esper Boel, M. E. Cooper	1999	41
5	Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine Diabetologia ·Edward Roufail, Tina Soulis, Esper Boel, M. E. Cooper, Sandra Rees	1998	55
6	Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells Diabetologia ·YasuyoshiSEKITA, Kim R. Hejnæs, M. O. Marshall, Nataliya B. Shepelyavaya, Esper Boel, I. Svendsen, E. K. Grebel, Thomas Dyrberg	1995	35
7	Diabetic late complications: Will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise? Journal of Diabetes and its Complications ·Esper Boel, Johan Selmer, Hans Flodgaard, Tonny Jensen	1995	47
8	A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM Diabetologia ·C. E. Grubin, T. Daniels, Bert Toivola, Mona Landin‐Olsson, William Hagopian, 一凡路, Allan E. Karlsen, Esper Boel, B Michelsen, Åke Lernmark	1994	351
9	Structure–function relationships in naturally occurring mutants of pancreatic lipase Protein Engineering Design and Selection ·Frédéric Carrière, Kenneth Thirstrup, Esper Boel, Robert Verger, Lars Thim	1994	34
10	Thiol ester role in correct folding and conformation of human α₂‐macroglobulin FEBS Letters ·Peter G.W. Gettins, Esper Boel, Brenda C. Crews	1994	13
11	Identification of Glutamic Acid Decarboxylase Autoantibody Heterogeneity and Epitope Regions in Type I Diabetes Diabetes ·P. Ohman, WU Ruifang, Roberto Gianani, Esper Boel, Liping Yu, Alvin C. Powers	1994	52
12	The inducible nitric oxide synthase gene, Nos2, maps to mouse Chromosome 11 Mammalian Genome ·Ivan Gerling, Allan E. Karlsen, H.D. Chapman, Henrik U. Andersen, Esper Boel, James M. Cunningham, J. Nerup, Edward H. Leiter	1994	12
13	Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family European Journal of Pharmacology Molecular Pharmacology ·Christian Thomsen, Esper Boel, Peter D. Suzdak	1994	124
14	Cloning of the classical guinea pig pancreatic lipase and comparison with the lipase related protein 2 FEBS Letters ·Frédéric Carrière, Kenneth Thirstrup, Siv A. Hjorth, Esper Boel	1994	52
15	Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. Journal of Clinical Investigation ·William Hagopian, Allan E. Karlsen, Anders Gottsäter, Mona Landin‐Olsson, C. E. Grubin, G. Sundkvist, J. Petersen, Esper Boel, Thomas Dyrberg, Åke Lernmark	1993	160
16	A structural domain (the lid) found in pancreatic lipases is absent in the guinea pig (phospho)lipase Biochemistry ·Siv A. Hjorth, Frédéric Carrière, Claire Cudrey, Helle F. Wöldike, Esper Boel, David M. Lawson, Francine Ferrato, Christian Cambillau, Guy Dodson	1993	152
17	Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides In Vitro Cellular & Developmental Biology - Animal ·Keld Kaltoft, S Bisballe, Thomas Dyrberg, Esper Boel, P. B. Rasmussen, Kristian Thestrup‐Pedersen	1992	114
18	Partial processing of the neuropeptide Y precursor in transfected CHO cells FEBS Letters ·Birgitte S. Wulff, M.M.T. O’Hare, Esper Boel, Lars E. Theill, Thue W. Schwartz	1990	26
19	Calcium binding in .alpha.-amylases: an x-ray diffraction study at 2.1-.ANG. resolution of two enzymes from Aspergillus Biochemistry ·Esper Boel, Leo Brady, A.M. Brzozowski, Zygmunt S. Derewenda, Guy Dodson, Gillian G. Leibach, Steffen B. Petersen, Orlane Anneville, L. Thim, Helle F. Wöldike	1990	269
20	Primary structure of a precursor to the asprartic proteinase from Rhizomucor miehei shows that the enzyme is synthesized as a zymogen Proteins Structure Function and Bioinformatics ·Esper Boel, Anne‐Marie Bech, Harold B. Lefcourt, Michael Jonkman, Maria Luiza A. Kalfelz, Bent Foltmann	1986	25

About Esper Boel

Esper Boel is a scholar working on Clinical Biochemistry, Biotechnology, Endocrinology, Diabetes and Metabolism, Cell Biology and Surgery, having authored 54 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (17 papers), Diabetes and associated disorders (9 papers), Enzyme Catalysis and Immobilization (6 papers), Enzyme Production and Characterization (6 papers), Neuropeptides and Animal Physiology (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Advanced Glycation End Products research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Biotechnology (732 citations), Endocrinology, Diabetes and Metabolism (916 citations), Genetics (1.2k citations), Surgery (1.2k citations) and Molecular Biology (1.7k citations). Esper Boel has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Niels P. Fiil, Allan E. Karlsen, Kjeld Norris, B Michelsen, Thomas Dyrberg, Lars Thim, Mogens Trier Hansen, William Hagopian, Åke Lernmark and C. E. Grubin. Their work appears in journals such as Diabetes, Diabetologia, Biochemistry, FEBS Letters and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact